European marketing authorization follows U.S. FDA clearance of eyonis LCS, Median's AI-based Software as a Medical Device designed to aid in the detection and diagnosis of lung cancer in screening ...
Transfer pricing principles dictate that a captive, risk-mitigated service provider could not be benchmarked against full-fledged, risk-bearing entrepreneurs, companies owning substantial intellectual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results